Cargando…

Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?

Introduction: Although pulmonary embolism (PE) is a frequent complication of the clinical course of COVID-19, there is a lack of explicit indications regarding the best algorithm for diagnosing PE in these patients. In particular, it is not clear how to identify subjects who should undergo computed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porfidia, Angelo, Mosoni, Carolina, Talerico, Rosa, Porceddu, Enrica, Lupascu, Andrea, Tondi, Paolo, Landi, Francesco, Pola, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414135/ https://www.ncbi.nlm.nih.gov/pubmed/34485411 http://dx.doi.org/10.3389/fcvm.2021.714003

Ejemplares similares

CT Pulmonary Angiography for the Diagnosis of Pulmonary Embolism in Patients with COVID-19: When, Why, and for Who?
por: Porfidia, Angelo, et al.
Publicado: (2021)

Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients
por: Santini, Paolo, et al.
Publicado: (2023)

Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymore
por: Porfidia, Angelo, et al.
Publicado: (2021)

A Single Center Retrospective Cohort Study Comparing Different Anticoagulants for the Treatment of Catheter-Related Thrombosis of the Upper Extremities in Women With Gynecologic and Breast Cancer
por: Porfidia, Angelo, et al.
Publicado: (2022)

Differences in Clinical Presentation, Rate of Pulmonary Embolism, and Risk Factors Among Patients With Deep Vein Thrombosis in Unusual Sites
por: Porfidia, Angelo, et al.
Publicado: (2019)

Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis: Response from original authors Pola et al
por: Porfidia, Angelo, et al.
Publicado: (2020)

Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: is there a role for pre-test probability scores and home treatment?
por: Porfidia, Angelo, et al.
Publicado: (2021)

Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines
por: Porfidia, Angelo, et al.
Publicado: (2020)

Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines
por: Porfidia, Angelo, et al.
Publicado: (2020)

Should We Ever Pace for Carotid Sinus Syndrome?
por: Parry, Steve W.
Publicado: (2020)

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19
por: Porfidia, Angelo, et al.
Publicado: (2022)

Bioimpedance Vector Analysis for Heart Failure: Should We Put It on the Agenda?
por: Liang, Bo, et al.
Publicado: (2021)

Should We Maintain Anticoagulation after Successful Radiofrequency Catheter Ablation of Atrial Fibrillation? The Need for a Randomized Study
por: Santarpia, Giuseppe, et al.
Publicado: (2017)

Microparticles Carrying Sonic Hedgehog Are Increased in Humans with Peripheral Artery Disease
por: Giarretta, Igor, et al.
Publicado: (2018)

Postprandial Hyperglycemia and Glycemic Variability: Should we care?
por: Standl, Eberhard, et al.
Publicado: (2011)

Which Reference Should We Use for EEG and ERP practice?
por: Yao, Dezhong, et al.
Publicado: (2019)

Which treatment modality should we choose for advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2010)

Which lipid measurement should we monitor? An analysis of the LIPID study
por: Glasziou, Paul P, et al.
Publicado: (2014)

Monitoring the prevalence of chronic conditions: which data should we use?
por: Orueta, Juan F, et al.
Publicado: (2012)

Determination of Zinc Status in Humans: Which Indicator Should We Use?
por: Wieringa, Frank T., et al.
Publicado: (2015)

Which experimental systems should we use for human microbiome science?
por: Douglas, Angela E.
Publicado: (2018)

Which Phenotypes Should We Include in the Hypoplastic Left Heart Syndrome?
por: Anderson, Robert H., et al.
Publicado: (2023)

Diagnostic Management of Pregnant Women With Suspected Pulmonary Embolism
por: Robert-Ebadi, Helia, et al.
Publicado: (2022)

Unpredictable Midterm Coronary Damage after Knuckle-reverse CART: Should We Be More Careful?
por: Levesque, Sébastien, et al.
Publicado: (2020)

Which Species Should We Focus On? Umbrella Species Assessment in Southwest China
por: Shi, Xuewei, et al.
Publicado: (2019)

Which reference range should we use for transgender and gender diverse patients?
por: Irwig, Michael S
Publicado: (2020)

Surgical radiofrequency ablation of atrial flutter: which operation should we choose?
por: Chen, Fengjie, et al.
Publicado: (2021)

Should we look for silent pulmonary embolism in patients with deep venous thrombosis?
por: García-Fuster, Maria José, et al.
Publicado: (2014)

High-risk Pulmonary Embolism: Should We Be Less Patient with Thrombolytic Therapy?
por: Yıldırım, Fatma, et al.
Publicado: (2017)

When should we involve interventional radiology in the management of acute pulmonary embolism?
por: Barca-Hernando, María, et al.
Publicado: (2023)

When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

Microcirculatory response to fluid challenge: should we prefer balanced colloids to rebalance tissue perfusion?
por: Donati, A, et al.
Publicado: (2013)

High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis
por: Valeriani, Emanuele, et al.
Publicado: (2022)

Targeting Postprandial Hyperglycemia With Physical Activity May Reduce Cardiovascular Disease Risk. But What Should We Do, and When Is the Right Time to Move?
por: Solomon, Thomas P. J., et al.
Publicado: (2018)

Tenecteplase compared with streptokinase and heparin in the treatment of pulmonary embolism: an observational study
por: Agrawal, Ashish, et al.
Publicado: (2017)

Why Should We Measure Low-Density Lipoprotein Cholesterol Directly? Comparison of Low-Density Lipoprotein Cholesterol Assessment by Friedewald Estimation, and Direct Measurement
por: Cohen, Hofit
Publicado: (2021)

Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use?
por: Karampetsou, Evangelia, et al.
Publicado: (2014)

All for one, but not one for all <Guideline needed; which and when should we use>
por: Notomi, Yuichi
Publicado: (2012)

Which intravascular access should we use in patients with suspected/confirmed COVID-19?
por: Smereka, Jacek, et al.
Publicado: (2020)

Which Electronic Health Record System Should We Use? A Systematic Review
por: Al Ani, Mohammed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e361ho23c2etdsa51brcd06382